zyxhaian
Lv1
20 积分
2022-08-04 加入
-
Axillary Dissection — The Bell Tolls for Thee
18天前
已完结
-
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
18天前
已完结
-
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
6个月前
已完结
-
cGAS–STING and the deadly CIN: how chronic inflammation represents a therapeutic vulnerability in chromosomally unstable cancers
7个月前
已完结
-
The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes
10个月前
已完结
-
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy
10个月前
已完结
-
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
10个月前
已完结
-
Pan-cancer single-cell landscape of tumor-infiltrating T cells
11个月前
已完结
-
Synchronous Bilateral Breast Cancers Are Distinct Diseases
1年前
已关闭
-
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)
1年前
已完结